0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Exosome Diagnostic and Therapeutic Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-35K13206
Home | Market Reports | Health| Nursing
Global Exosome Diagnostic and Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Exosome Diagnostic and Therapeutic Market Insights, Forecast to 2030

Code: QYRE-Auto-35K13206
Report
December 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Exosome Diagnostic and Therapeutic Market Size

The global Exosome Diagnostic and Therapeutic market is projected to grow from US$ 136.9 million in 2024 to US$ 825.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 34.9% during the forecast period.

Exosome Diagnostic and Therapeutic Market

Exosome Diagnostic and Therapeutic Market

Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine and cultured medium of cell cultures.
Market Analysis and Insights: Global Exosome Diagnostic and Therapeutic Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Exosome Diagnostic and Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Exosome Diagnostic and Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Exosome Diagnostic and Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Exosome Diagnostic and Therapeutic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Exosome Diagnostic and Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Exosome Diagnostic and Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Exosome Diagnostic and Therapeutic Market Report

Report Metric Details
Report Name Exosome Diagnostic and Therapeutic Market
Accounted market size in 2024 US$ 136.9 million
Forecasted market size in 2030 US$ 825.8 million
CAGR 34.9
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Instrument
  • Reagent
  • Software
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Norgen Biotek
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Exosome Diagnostic and Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Exosome Diagnostic and Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Diagnostic and Therapeutic revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Exosome Diagnostic and Therapeutic Market growing?

Ans: The Exosome Diagnostic and Therapeutic Market witnessing a CAGR of 34.9 during the forecast period 2025-2030.

What is the Exosome Diagnostic and Therapeutic Market size in 2030?

Ans: The Exosome Diagnostic and Therapeutic Market size in 2030 will be US$ 825.8 million.

Who are the main players in the Exosome Diagnostic and Therapeutic Market report?

Ans: The main players in the Exosome Diagnostic and Therapeutic Market are AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Norgen Biotek

What are the Application segmentation covered in the Exosome Diagnostic and Therapeutic Market report?

Ans: The Applications covered in the Exosome Diagnostic and Therapeutic Market report are Cancer Institute, Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the Exosome Diagnostic and Therapeutic Market report?

Ans: The Types covered in the Exosome Diagnostic and Therapeutic Market report are Instrument, Reagent, Software

Recommended Reports

Exosome Technologies

Cancer Diagnostics

Clinical Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Instrument
1.2.3 Reagent
1.2.4 Software
1.3 Market by Application
1.3.1 Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer Institute
1.3.3 Hospital
1.3.4 Diagnostic Center
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Diagnostic and Therapeutic Market Perspective (2019-2030)
2.2 Global Exosome Diagnostic and Therapeutic Growth Trends by Region
2.2.1 Exosome Diagnostic and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Diagnostic and Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Exosome Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Exosome Diagnostic and Therapeutic Market Dynamics
2.3.1 Exosome Diagnostic and Therapeutic Industry Trends
2.3.2 Exosome Diagnostic and Therapeutic Market Drivers
2.3.3 Exosome Diagnostic and Therapeutic Market Challenges
2.3.4 Exosome Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Exosome Diagnostic and Therapeutic by Players
3.1.1 Global Exosome Diagnostic and Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Exosome Diagnostic and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Exosome Diagnostic and Therapeutic, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Exosome Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Exosome Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostic and Therapeutic Revenue in 2023
3.5 Global Key Players of Exosome Diagnostic and Therapeutic Head office and Area Served
3.6 Global Key Players of Exosome Diagnostic and Therapeutic, Product and Application
3.7 Global Key Players of Exosome Diagnostic and Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Exosome Diagnostic and Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030)
5 Exosome Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Exosome Diagnostic and Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Diagnostic and Therapeutic Market Size (2019-2030)
6.2 North America Exosome Diagnostic and Therapeutic Market Size by Type
6.2.1 North America Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024)
6.2.2 North America Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030)
6.2.3 North America Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
6.3 North America Exosome Diagnostic and Therapeutic Market Size by Application
6.3.1 North America Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024)
6.3.2 North America Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030)
6.3.3 North America Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
6.4 North America Exosome Diagnostic and Therapeutic Market Size by Country
6.4.1 North America Exosome Diagnostic and Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Exosome Diagnostic and Therapeutic Market Size by Country (2019-2024)
6.4.3 North America Exosome Diagnostic and Therapeutic Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Exosome Diagnostic and Therapeutic Market Size (2019-2030)
7.2 Europe Exosome Diagnostic and Therapeutic Market Size by Type
7.2.1 Europe Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024)
7.2.2 Europe Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030)
7.2.3 Europe Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
7.3 Europe Exosome Diagnostic and Therapeutic Market Size by Application
7.3.1 Europe Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024)
7.3.2 Europe Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030)
7.3.3 Europe Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
7.4 Europe Exosome Diagnostic and Therapeutic Market Size by Country
7.4.1 Europe Exosome Diagnostic and Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Exosome Diagnostic and Therapeutic Market Size by Country (2019-2024)
7.4.3 Europe Exosome Diagnostic and Therapeutic Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Exosome Diagnostic and Therapeutic Market Size (2019-2030)
8.2 China Exosome Diagnostic and Therapeutic Market Size by Type
8.2.1 China Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024)
8.2.2 China Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030)
8.2.3 China Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
8.3 China Exosome Diagnostic and Therapeutic Market Size by Application
8.3.1 China Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024)
8.3.2 China Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030)
8.3.3 China Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Exosome Diagnostic and Therapeutic Market Size (2019-2030)
9.2 Asia Exosome Diagnostic and Therapeutic Market Size by Type
9.2.1 Asia Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024)
9.2.2 Asia Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030)
9.2.3 Asia Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
9.3 Asia Exosome Diagnostic and Therapeutic Market Size by Application
9.3.1 Asia Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024)
9.3.2 Asia Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030)
9.3.3 Asia Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
9.4 Asia Exosome Diagnostic and Therapeutic Market Size by Region
9.4.1 Asia Exosome Diagnostic and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Exosome Diagnostic and Therapeutic Market Size by Region (2019-2024)
9.4.3 Asia Exosome Diagnostic and Therapeutic Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AMS Biotechnology
11.1.1 AMS Biotechnology Company Details
11.1.2 AMS Biotechnology Business Overview
11.1.3 AMS Biotechnology Exosome Diagnostic and Therapeutic Introduction
11.1.4 AMS Biotechnology Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024)
11.1.5 AMS Biotechnology Recent Developments
11.2 ReNeuron
11.2.1 ReNeuron Company Details
11.2.2 ReNeuron Business Overview
11.2.3 ReNeuron Exosome Diagnostic and Therapeutic Introduction
11.2.4 ReNeuron Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024)
11.2.5 ReNeuron Recent Developments
11.3 ExoCyte Therapeutics
11.3.1 ExoCyte Therapeutics Company Details
11.3.2 ExoCyte Therapeutics Business Overview
11.3.3 ExoCyte Therapeutics Exosome Diagnostic and Therapeutic Introduction
11.3.4 ExoCyte Therapeutics Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024)
11.3.5 ExoCyte Therapeutics Recent Developments
11.4 Cell Guidance Systems
11.4.1 Cell Guidance Systems Company Details
11.4.2 Cell Guidance Systems Business Overview
11.4.3 Cell Guidance Systems Exosome Diagnostic and Therapeutic Introduction
11.4.4 Cell Guidance Systems Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024)
11.4.5 Cell Guidance Systems Recent Developments
11.5 BioRegenerative Sciences
11.5.1 BioRegenerative Sciences Company Details
11.5.2 BioRegenerative Sciences Business Overview
11.5.3 BioRegenerative Sciences Exosome Diagnostic and Therapeutic Introduction
11.5.4 BioRegenerative Sciences Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024)
11.5.5 BioRegenerative Sciences Recent Developments
11.6 Norgen Biotek
11.6.1 Norgen Biotek Company Details
11.6.2 Norgen Biotek Business Overview
11.6.3 Norgen Biotek Exosome Diagnostic and Therapeutic Introduction
11.6.4 Norgen Biotek Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024)
11.6.5 Norgen Biotek Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Instrument
    Table 3. Key Players of Reagent
    Table 4. Key Players of Software
    Table 5. Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Exosome Diagnostic and Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Exosome Diagnostic and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Exosome Diagnostic and Therapeutic Market Share by Region (2019-2024)
    Table 9. Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Exosome Diagnostic and Therapeutic Market Share by Region (2025-2030)
    Table 11. Exosome Diagnostic and Therapeutic Market Trends
    Table 12. Exosome Diagnostic and Therapeutic Market Drivers
    Table 13. Exosome Diagnostic and Therapeutic Market Challenges
    Table 14. Exosome Diagnostic and Therapeutic Market Restraints
    Table 15. Global Exosome Diagnostic and Therapeutic Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Exosome Diagnostic and Therapeutic Revenue Share by Players (2019-2024)
    Table 17. Global Top Exosome Diagnostic and Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostic and Therapeutic as of 2023)
    Table 18. Global Exosome Diagnostic and Therapeutic Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Exosome Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Exosome Diagnostic and Therapeutic, Headquarters and Area Served
    Table 21. Global Key Players of Exosome Diagnostic and Therapeutic, Product and Application
    Table 22. Global Key Players of Exosome Diagnostic and Therapeutic, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Exosome Diagnostic and Therapeutic Revenue Market Share by Type (2019-2024)
    Table 26. Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Exosome Diagnostic and Therapeutic Revenue Market Share by Type (2025-2030)
    Table 28. Global Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Exosome Diagnostic and Therapeutic Revenue Share by Application (2019-2024)
    Table 30. Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Exosome Diagnostic and Therapeutic Revenue Share by Application (2025-2030)
    Table 32. North America Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Exosome Diagnostic and Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Exosome Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Exosome Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Exosome Diagnostic and Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Exosome Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Exosome Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Exosome Diagnostic and Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Exosome Diagnostic and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Exosome Diagnostic and Therapeutic Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 64. AMS Biotechnology Company Details
    Table 65. AMS Biotechnology Business Overview
    Table 66. AMS Biotechnology Exosome Diagnostic and Therapeutic Product
    Table 67. AMS Biotechnology Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 68. AMS Biotechnology Recent Developments
    Table 69. ReNeuron Company Details
    Table 70. ReNeuron Business Overview
    Table 71. ReNeuron Exosome Diagnostic and Therapeutic Product
    Table 72. ReNeuron Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 73. ReNeuron Recent Developments
    Table 74. ExoCyte Therapeutics Company Details
    Table 75. ExoCyte Therapeutics Business Overview
    Table 76. ExoCyte Therapeutics Exosome Diagnostic and Therapeutic Product
    Table 77. ExoCyte Therapeutics Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 78. ExoCyte Therapeutics Recent Developments
    Table 79. Cell Guidance Systems Company Details
    Table 80. Cell Guidance Systems Business Overview
    Table 81. Cell Guidance Systems Exosome Diagnostic and Therapeutic Product
    Table 82. Cell Guidance Systems Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 83. Cell Guidance Systems Recent Developments
    Table 84. BioRegenerative Sciences Company Details
    Table 85. BioRegenerative Sciences Business Overview
    Table 86. BioRegenerative Sciences Exosome Diagnostic and Therapeutic Product
    Table 87. BioRegenerative Sciences Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 88. BioRegenerative Sciences Recent Developments
    Table 89. Norgen Biotek Company Details
    Table 90. Norgen Biotek Business Overview
    Table 91. Norgen Biotek Exosome Diagnostic and Therapeutic Product
    Table 92. Norgen Biotek Revenue in Exosome Diagnostic and Therapeutic Business (2019-2024) & (US$ Million)
    Table 93. Norgen Biotek Recent Developments
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Exosome Diagnostic and Therapeutic Market Share by Type: 2023 VS 2030
    Figure 3. Instrument Features
    Figure 4. Reagent Features
    Figure 5. Software Features
    Figure 6. Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Exosome Diagnostic and Therapeutic Market Share by Application: 2023 VS 2030
    Figure 8. Cancer Institute Case Studies
    Figure 9. Hospital Case Studies
    Figure 10. Diagnostic Center Case Studies
    Figure 11. Others Case Studies
    Figure 12. Exosome Diagnostic and Therapeutic Report Years Considered
    Figure 13. Global Exosome Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Exosome Diagnostic and Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Exosome Diagnostic and Therapeutic Market Share by Region: 2023 VS 2030
    Figure 16. Global Exosome Diagnostic and Therapeutic Market Share by Players in 2023
    Figure 17. Global Top Exosome Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostic and Therapeutic as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Exosome Diagnostic and Therapeutic Revenue in 2023
    Figure 19. North America Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 21. North America Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 22. North America Exosome Diagnostic and Therapeutic Market Share by Country (2019-2030)
    Figure 23. United States Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Exosome Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 27. Europe Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 28. Europe Exosome Diagnostic and Therapeutic Market Share by Country (2019-2030)
    Figure 29. Germany Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Exosome Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 37. China Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 38. Asia Exosome Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 40. Asia Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 41. Asia Exosome Diagnostic and Therapeutic Market Share by Region (2019-2030)
    Figure 42. Japan Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Exosome Diagnostic and Therapeutic Market Share by Country (2019-2030)
    Figure 52. Brazil Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Exosome Diagnostic and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. AMS Biotechnology Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2019-2024)
    Figure 59. ReNeuron Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2019-2024)
    Figure 60. ExoCyte Therapeutics Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2019-2024)
    Figure 61. Cell Guidance Systems Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2019-2024)
    Figure 62. BioRegenerative Sciences Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2019-2024)
    Figure 63. Norgen Biotek Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart